Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02543645
Title A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celldex Therapeutics
Indications

urinary bladder cancer

head and neck cancer

triple-receptor negative breast cancer

renal cell carcinoma

lung non-small cell carcinoma

melanoma

Therapies

Atezolizumab + Varlilumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California - San Francisco San Francisco California 94550 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field